nodes	percent_of_prediction	percent_of_DWPC	metapath
Metformin—NDUFA12—bone cancer	0.494	1	CbGaD
Metformin—NDUFS7—Doxorubicin—bone cancer	0.103	0.321	CbGbCtD
Metformin—NDUFS3—Doxorubicin—bone cancer	0.103	0.321	CbGbCtD
Metformin—NDUFS2—Doxorubicin—bone cancer	0.103	0.321	CbGbCtD
Metformin—SLC22A2—Cisplatin—bone cancer	0.0113	0.0354	CbGbCtD
Metformin—NDUFA1—connective tissue—bone cancer	0.000652	0.0152	CbGeAlD
Metformin—NDUFV2—connective tissue—bone cancer	0.000633	0.0148	CbGeAlD
Metformin—NDUFA7—tendon—bone cancer	0.000544	0.0127	CbGeAlD
Metformin—NDUFA5—connective tissue—bone cancer	0.000491	0.0114	CbGeAlD
Metformin—NDUFAF4—connective tissue—bone cancer	0.000487	0.0113	CbGeAlD
Metformin—NDUFS1—connective tissue—bone cancer	0.000483	0.0113	CbGeAlD
Metformin—NDUFB10—connective tissue—bone cancer	0.00048	0.0112	CbGeAlD
Metformin—NDUFA6—connective tissue—bone cancer	0.000467	0.0109	CbGeAlD
Metformin—NDUFS4—connective tissue—bone cancer	0.000464	0.0108	CbGeAlD
Metformin—NDUFB4—connective tissue—bone cancer	0.000458	0.0107	CbGeAlD
Metformin—NDUFAB1—connective tissue—bone cancer	0.000455	0.0106	CbGeAlD
Metformin—NDUFB9—connective tissue—bone cancer	0.000452	0.0105	CbGeAlD
Metformin—NDUFV1—connective tissue—bone cancer	0.000447	0.0104	CbGeAlD
Metformin—NDUFB8—connective tissue—bone cancer	0.000444	0.0104	CbGeAlD
Metformin—NDUFS5—connective tissue—bone cancer	0.000444	0.0104	CbGeAlD
Metformin—NDUFA4L2—tendon—bone cancer	0.000423	0.00987	CbGeAlD
Metformin—NDUFS7—connective tissue—bone cancer	0.000416	0.0097	CbGeAlD
Metformin—NDUFA4L2—spinal cord—bone cancer	0.000408	0.00952	CbGeAlD
Metformin—ND4L—bone marrow—bone cancer	0.000386	0.00899	CbGeAlD
Metformin—ND5—bone marrow—bone cancer	0.000386	0.00899	CbGeAlD
Metformin—ND3—bone marrow—bone cancer	0.000386	0.00899	CbGeAlD
Metformin—ND2—bone marrow—bone cancer	0.000386	0.00899	CbGeAlD
Metformin—NDUFA2—tendon—bone cancer	0.000377	0.0088	CbGeAlD
Metformin—ND4—bone marrow—bone cancer	0.000373	0.0087	CbGeAlD
Metformin—NDUFA2—bone marrow—bone cancer	0.000366	0.00852	CbGeAlD
Metformin—NDUFA2—spinal cord—bone cancer	0.000364	0.00848	CbGeAlD
Metformin—NDUFA10—tendon—bone cancer	0.00036	0.00839	CbGeAlD
Metformin—NDUFC1—tendon—bone cancer	0.000357	0.00832	CbGeAlD
Metformin—NDUFB2—tendon—bone cancer	0.000354	0.00825	CbGeAlD
Metformin—NDUFAF1—tendon—bone cancer	0.000351	0.00818	CbGeAlD
Metformin—NDUFA10—bone marrow—bone cancer	0.000349	0.00813	CbGeAlD
Metformin—NDUFA10—spinal cord—bone cancer	0.000347	0.00809	CbGeAlD
Metformin—NDUFC1—bone marrow—bone cancer	0.000346	0.00806	CbGeAlD
Metformin—NDUFB3—tendon—bone cancer	0.000345	0.00805	CbGeAlD
Metformin—NDUFAF2—tendon—bone cancer	0.000345	0.00805	CbGeAlD
Metformin—NDUFS2—connective tissue—bone cancer	0.000345	0.00804	CbGeAlD
Metformin—NDUFC1—spinal cord—bone cancer	0.000344	0.00802	CbGeAlD
Metformin—NDUFB2—bone marrow—bone cancer	0.000343	0.00799	CbGeAlD
Metformin—NDUFB2—spinal cord—bone cancer	0.000341	0.00795	CbGeAlD
Metformin—NDUFS3—connective tissue—bone cancer	0.000341	0.00794	CbGeAlD
Metformin—NDUFAF1—bone marrow—bone cancer	0.00034	0.00792	CbGeAlD
Metformin—NDUFAF1—spinal cord—bone cancer	0.000338	0.00789	CbGeAlD
Metformin—NDUFA11—tendon—bone cancer	0.000337	0.00786	CbGeAlD
Metformin—ND6—bone marrow—bone cancer	0.000337	0.00786	CbGeAlD
Metformin—NDUFAF4—tendon—bone cancer	0.000335	0.0078	CbGeAlD
Metformin—NDUFB6—tendon—bone cancer	0.000335	0.0078	CbGeAlD
Metformin—NDUFB3—bone marrow—bone cancer	0.000334	0.00779	CbGeAlD
Metformin—NDUFAF2—bone marrow—bone cancer	0.000334	0.00779	CbGeAlD
Metformin—NDUFAF2—spinal cord—bone cancer	0.000333	0.00776	CbGeAlD
Metformin—NDUFB3—spinal cord—bone cancer	0.000333	0.00776	CbGeAlD
Metformin—NDUFS1—tendon—bone cancer	0.000332	0.00774	CbGeAlD
Metformin—NDUFB10—tendon—bone cancer	0.00033	0.00769	CbGeAlD
Metformin—NDUFA12—tendon—bone cancer	0.000328	0.00763	CbGeAlD
Metformin—NDUFB7—tendon—bone cancer	0.000328	0.00763	CbGeAlD
Metformin—NDUFA5—bone marrow—bone cancer	0.000327	0.00761	CbGeAlD
Metformin—NDUFS8—tendon—bone cancer	0.000325	0.00758	CbGeAlD
Metformin—NDUFB1—tendon—bone cancer	0.000325	0.00758	CbGeAlD
Metformin—NDUFA11—spinal cord—bone cancer	0.000325	0.00758	CbGeAlD
Metformin—NDUFAF4—bone marrow—bone cancer	0.000324	0.00756	CbGeAlD
Metformin—NDUFB6—bone marrow—bone cancer	0.000324	0.00756	CbGeAlD
Metformin—NDUFB6—spinal cord—bone cancer	0.000323	0.00752	CbGeAlD
Metformin—NDUFAF4—spinal cord—bone cancer	0.000323	0.00752	CbGeAlD
Metformin—NDUFS1—bone marrow—bone cancer	0.000322	0.0075	CbGeAlD
Metformin—NDUFB5—tendon—bone cancer	0.000321	0.00748	CbGeAlD
Metformin—NDUFA6—tendon—bone cancer	0.000321	0.00748	CbGeAlD
Metformin—NDUFS1—spinal cord—bone cancer	0.00032	0.00747	CbGeAlD
Metformin—NDUFB10—bone marrow—bone cancer	0.00032	0.00745	CbGeAlD
Metformin—NDUFS4—tendon—bone cancer	0.000319	0.00743	CbGeAlD
Metformin—NDUFB10—spinal cord—bone cancer	0.000318	0.00742	CbGeAlD
Metformin—NDUFA12—bone marrow—bone cancer	0.000317	0.0074	CbGeAlD
Metformin—NDUFB7—bone marrow—bone cancer	0.000317	0.0074	CbGeAlD
Metformin—NDUFB7—spinal cord—bone cancer	0.000316	0.00736	CbGeAlD
Metformin—NDUFA12—spinal cord—bone cancer	0.000316	0.00736	CbGeAlD
Metformin—NDUFB1—bone marrow—bone cancer	0.000315	0.00734	CbGeAlD
Metformin—NDUFS8—bone marrow—bone cancer	0.000315	0.00734	CbGeAlD
Metformin—NDUFB4—tendon—bone cancer	0.000315	0.00734	CbGeAlD
Metformin—NDUFS8—spinal cord—bone cancer	0.000314	0.00731	CbGeAlD
Metformin—NDUFB1—spinal cord—bone cancer	0.000314	0.00731	CbGeAlD
Metformin—NDUFAB1—tendon—bone cancer	0.000313	0.00729	CbGeAlD
Metformin—NDUFB5—bone marrow—bone cancer	0.000311	0.00724	CbGeAlD
Metformin—NDUFA6—bone marrow—bone cancer	0.000311	0.00724	CbGeAlD
Metformin—NDUFB9—tendon—bone cancer	0.000311	0.00724	CbGeAlD
Metformin—NDUFA8—tendon—bone cancer	0.000311	0.00724	CbGeAlD
Metformin—NDUFA6—spinal cord—bone cancer	0.000309	0.00721	CbGeAlD
Metformin—NDUFB5—spinal cord—bone cancer	0.000309	0.00721	CbGeAlD
Metformin—NDUFA4—tendon—bone cancer	0.000309	0.0072	CbGeAlD
Metformin—NDUFS4—bone marrow—bone cancer	0.000309	0.0072	CbGeAlD
Metformin—NDUFS4—spinal cord—bone cancer	0.000307	0.00717	CbGeAlD
Metformin—NDUFV1—tendon—bone cancer	0.000307	0.00716	CbGeAlD
Metformin—NDUFB11—tendon—bone cancer	0.000307	0.00716	CbGeAlD
Metformin—NDUFS5—tendon—bone cancer	0.000305	0.00711	CbGeAlD
Metformin—NDUFB8—tendon—bone cancer	0.000305	0.00711	CbGeAlD
Metformin—NDUFB4—bone marrow—bone cancer	0.000305	0.0071	CbGeAlD
Metformin—NDUFB4—spinal cord—bone cancer	0.000304	0.00707	CbGeAlD
Metformin—NDUFAB1—bone marrow—bone cancer	0.000303	0.00706	CbGeAlD
Metformin—NDUFAB1—spinal cord—bone cancer	0.000302	0.00703	CbGeAlD
Metformin—NDUFA8—bone marrow—bone cancer	0.000301	0.00702	CbGeAlD
Metformin—NDUFB9—bone marrow—bone cancer	0.000301	0.00702	CbGeAlD
Metformin—NDUFA8—spinal cord—bone cancer	0.0003	0.00699	CbGeAlD
Metformin—NDUFB9—spinal cord—bone cancer	0.0003	0.00699	CbGeAlD
Metformin—NDUFA4—bone marrow—bone cancer	0.000299	0.00697	CbGeAlD
Metformin—NDUFA4—spinal cord—bone cancer	0.000298	0.00694	CbGeAlD
Metformin—NDUFB11—bone marrow—bone cancer	0.000297	0.00693	CbGeAlD
Metformin—NDUFV1—bone marrow—bone cancer	0.000297	0.00693	CbGeAlD
Metformin—NDUFV1—spinal cord—bone cancer	0.000296	0.0069	CbGeAlD
Metformin—NDUFB11—spinal cord—bone cancer	0.000296	0.0069	CbGeAlD
Metformin—NDUFS5—bone marrow—bone cancer	0.000296	0.00689	CbGeAlD
Metformin—NDUFB8—bone marrow—bone cancer	0.000296	0.00689	CbGeAlD
Metformin—NDUFS5—spinal cord—bone cancer	0.000294	0.00686	CbGeAlD
Metformin—NDUFB8—spinal cord—bone cancer	0.000294	0.00686	CbGeAlD
Metformin—NDUFS7—tendon—bone cancer	0.000286	0.00667	CbGeAlD
Metformin—NDUFS7—bone marrow—bone cancer	0.000277	0.00646	CbGeAlD
Metformin—NDUFS7—spinal cord—bone cancer	0.000276	0.00643	CbGeAlD
Metformin—PRKAB1—tendon—bone cancer	0.000262	0.0061	CbGeAlD
Metformin—PRKAB1—bone marrow—bone cancer	0.000253	0.00591	CbGeAlD
Metformin—PRKAB1—spinal cord—bone cancer	0.000252	0.00588	CbGeAlD
Metformin—NDUFC2—tendon—bone cancer	0.000247	0.00575	CbGeAlD
Metformin—NDUFC2—bone marrow—bone cancer	0.000239	0.00557	CbGeAlD
Metformin—NDUFC2—spinal cord—bone cancer	0.000238	0.00554	CbGeAlD
Metformin—NDUFS2—tendon—bone cancer	0.000237	0.00552	CbGeAlD
Metformin—NDUFS3—tendon—bone cancer	0.000234	0.00546	CbGeAlD
Metformin—NDUFS2—bone marrow—bone cancer	0.00023	0.00535	CbGeAlD
Metformin—NDUFS2—spinal cord—bone cancer	0.000229	0.00533	CbGeAlD
Metformin—NDUFS3—bone marrow—bone cancer	0.000227	0.00529	CbGeAlD
Metformin—NDUFS3—spinal cord—bone cancer	0.000226	0.00526	CbGeAlD
Metformin—ND1—bone marrow—bone cancer	0.000188	0.00439	CbGeAlD
Metformin—SLC22A3—connective tissue—bone cancer	0.000153	0.00357	CbGeAlD
Metformin—Neuropathy—Doxorubicin—bone cancer	0.000136	0.00465	CcSEcCtD
Metformin—Erythema—Cisplatin—bone cancer	0.000134	0.00456	CcSEcCtD
Metformin—Malnutrition—Cisplatin—bone cancer	0.000134	0.00456	CcSEcCtD
Metformin—SLC47A1—tendon—bone cancer	0.000132	0.00308	CbGeAlD
Metformin—Flatulence—Cisplatin—bone cancer	0.000132	0.00449	CcSEcCtD
Metformin—Muscle spasms—Cisplatin—bone cancer	0.000129	0.00438	CcSEcCtD
Metformin—SLC47A1—spinal cord—bone cancer	0.000127	0.00297	CbGeAlD
Metformin—Vision blurred—Cisplatin—bone cancer	0.000126	0.00429	CcSEcCtD
Metformin—Tremor—Cisplatin—bone cancer	0.000125	0.00427	CcSEcCtD
Metformin—Lethargy—Methotrexate—bone cancer	0.000124	0.00424	CcSEcCtD
Metformin—Ill-defined disorder—Cisplatin—bone cancer	0.000124	0.00423	CcSEcCtD
Metformin—Malaise—Cisplatin—bone cancer	0.000121	0.00411	CcSEcCtD
Metformin—Renal impairment—Epirubicin—bone cancer	0.00012	0.00408	CcSEcCtD
Metformin—Hypoglycaemia—Epirubicin—bone cancer	0.000117	0.00398	CcSEcCtD
Metformin—Lethargy—Epirubicin—bone cancer	0.000116	0.00397	CcSEcCtD
Metformin—Pain in extremity—Epirubicin—bone cancer	0.000114	0.00389	CcSEcCtD
Metformin—Myalgia—Cisplatin—bone cancer	0.000114	0.00388	CcSEcCtD
Metformin—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—bone cancer	0.000113	0.00385	CcSEcCtD
Metformin—Liver function test abnormal—Methotrexate—bone cancer	0.000112	0.00383	CcSEcCtD
Metformin—Discomfort—Cisplatin—bone cancer	0.000112	0.00383	CcSEcCtD
Metformin—Migraine—Epirubicin—bone cancer	0.000112	0.00382	CcSEcCtD
Metformin—Renal impairment—Doxorubicin—bone cancer	0.000111	0.00378	CcSEcCtD
Metformin—Breast disorder—Methotrexate—bone cancer	0.00011	0.00375	CcSEcCtD
Metformin—Oedema—Cisplatin—bone cancer	0.000109	0.00372	CcSEcCtD
Metformin—Infection—Cisplatin—bone cancer	0.000108	0.00369	CcSEcCtD
Metformin—Hypoglycaemia—Doxorubicin—bone cancer	0.000108	0.00368	CcSEcCtD
Metformin—Lethargy—Doxorubicin—bone cancer	0.000108	0.00367	CcSEcCtD
Metformin—Nervous system disorder—Cisplatin—bone cancer	0.000107	0.00365	CcSEcCtD
Metformin—Thrombocytopenia—Cisplatin—bone cancer	0.000107	0.00364	CcSEcCtD
Metformin—Dehydration—Epirubicin—bone cancer	0.000106	0.00361	CcSEcCtD
Metformin—Skin disorder—Cisplatin—bone cancer	0.000106	0.00361	CcSEcCtD
Metformin—Pain in extremity—Doxorubicin—bone cancer	0.000105	0.0036	CcSEcCtD
Metformin—Hyperhidrosis—Cisplatin—bone cancer	0.000105	0.0036	CcSEcCtD
Metformin—Liver function test abnormal—Epirubicin—bone cancer	0.000105	0.00359	CcSEcCtD
Metformin—Abdominal pain upper—Epirubicin—bone cancer	0.000104	0.00355	CcSEcCtD
Metformin—Anorexia—Cisplatin—bone cancer	0.000104	0.00354	CcSEcCtD
Metformin—Migraine—Doxorubicin—bone cancer	0.000104	0.00354	CcSEcCtD
Metformin—Pancreatitis—Methotrexate—bone cancer	0.000103	0.00352	CcSEcCtD
Metformin—Breast disorder—Epirubicin—bone cancer	0.000103	0.00351	CcSEcCtD
Metformin—Hypotension—Cisplatin—bone cancer	0.000102	0.00348	CcSEcCtD
Metformin—Nasopharyngitis—Epirubicin—bone cancer	0.000102	0.00347	CcSEcCtD
Metformin—Abdominal discomfort—Methotrexate—bone cancer	0.000101	0.00344	CcSEcCtD
Metformin—Musculoskeletal discomfort—Cisplatin—bone cancer	9.94e-05	0.00339	CcSEcCtD
Metformin—Abdominal distension—Epirubicin—bone cancer	9.92e-05	0.00338	CcSEcCtD
Metformin—Influenza—Epirubicin—bone cancer	9.85e-05	0.00336	CcSEcCtD
Metformin—Neutropenia—Methotrexate—bone cancer	9.85e-05	0.00336	CcSEcCtD
Metformin—Dehydration—Doxorubicin—bone cancer	9.81e-05	0.00334	CcSEcCtD
Metformin—Paraesthesia—Cisplatin—bone cancer	9.8e-05	0.00334	CcSEcCtD
Metformin—Upper respiratory tract infection—Methotrexate—bone cancer	9.79e-05	0.00334	CcSEcCtD
Metformin—Liver function test abnormal—Doxorubicin—bone cancer	9.74e-05	0.00332	CcSEcCtD
Metformin—Dyspnoea—Cisplatin—bone cancer	9.73e-05	0.00332	CcSEcCtD
Metformin—Pancreatitis—Epirubicin—bone cancer	9.66e-05	0.00329	CcSEcCtD
Metformin—Abdominal pain upper—Doxorubicin—bone cancer	9.63e-05	0.00328	CcSEcCtD
Metformin—Angina pectoris—Epirubicin—bone cancer	9.6e-05	0.00327	CcSEcCtD
Metformin—Breast disorder—Doxorubicin—bone cancer	9.53e-05	0.00325	CcSEcCtD
Metformin—Decreased appetite—Cisplatin—bone cancer	9.49e-05	0.00323	CcSEcCtD
Metformin—Nasopharyngitis—Doxorubicin—bone cancer	9.43e-05	0.00322	CcSEcCtD
Metformin—Gastrointestinal disorder—Cisplatin—bone cancer	9.42e-05	0.00321	CcSEcCtD
Metformin—Infestation NOS—Methotrexate—bone cancer	9.39e-05	0.0032	CcSEcCtD
Metformin—Infestation—Methotrexate—bone cancer	9.39e-05	0.0032	CcSEcCtD
Metformin—Drowsiness—Methotrexate—bone cancer	9.39e-05	0.0032	CcSEcCtD
Metformin—Neutropenia—Epirubicin—bone cancer	9.21e-05	0.00314	CcSEcCtD
Metformin—Abdominal distension—Doxorubicin—bone cancer	9.18e-05	0.00313	CcSEcCtD
Metformin—Upper respiratory tract infection—Epirubicin—bone cancer	9.16e-05	0.00312	CcSEcCtD
Metformin—Influenza—Doxorubicin—bone cancer	9.12e-05	0.00311	CcSEcCtD
Metformin—Feeling abnormal—Cisplatin—bone cancer	8.99e-05	0.00306	CcSEcCtD
Metformin—Pancreatitis—Doxorubicin—bone cancer	8.94e-05	0.00305	CcSEcCtD
Metformin—Angina pectoris—Doxorubicin—bone cancer	8.88e-05	0.00303	CcSEcCtD
Metformin—Hepatobiliary disease—Methotrexate—bone cancer	8.88e-05	0.00303	CcSEcCtD
Metformin—Infestation NOS—Epirubicin—bone cancer	8.79e-05	0.00299	CcSEcCtD
Metformin—Infestation—Epirubicin—bone cancer	8.79e-05	0.00299	CcSEcCtD
Metformin—Drowsiness—Epirubicin—bone cancer	8.79e-05	0.00299	CcSEcCtD
Metformin—Neuropathy peripheral—Epirubicin—bone cancer	8.61e-05	0.00294	CcSEcCtD
Metformin—Neutropenia—Doxorubicin—bone cancer	8.53e-05	0.00291	CcSEcCtD
Metformin—Upper respiratory tract infection—Doxorubicin—bone cancer	8.47e-05	0.00289	CcSEcCtD
Metformin—Hepatitis—Methotrexate—bone cancer	8.43e-05	0.00287	CcSEcCtD
Metformin—Hepatobiliary disease—Epirubicin—bone cancer	8.31e-05	0.00283	CcSEcCtD
Metformin—Drowsiness—Doxorubicin—bone cancer	8.13e-05	0.00277	CcSEcCtD
Metformin—Infestation NOS—Doxorubicin—bone cancer	8.13e-05	0.00277	CcSEcCtD
Metformin—Infestation—Doxorubicin—bone cancer	8.13e-05	0.00277	CcSEcCtD
Metformin—Bradycardia—Epirubicin—bone cancer	8.03e-05	0.00274	CcSEcCtD
Metformin—Neuropathy peripheral—Doxorubicin—bone cancer	7.97e-05	0.00272	CcSEcCtD
Metformin—Rhinitis—Epirubicin—bone cancer	7.91e-05	0.00269	CcSEcCtD
Metformin—Hepatitis—Epirubicin—bone cancer	7.89e-05	0.00269	CcSEcCtD
Metformin—Eye disorder—Methotrexate—bone cancer	7.88e-05	0.00268	CcSEcCtD
Metformin—Hypoaesthesia—Epirubicin—bone cancer	7.85e-05	0.00267	CcSEcCtD
Metformin—Asthenia—Cisplatin—bone cancer	7.83e-05	0.00267	CcSEcCtD
Metformin—Cardiac disorder—Methotrexate—bone cancer	7.82e-05	0.00267	CcSEcCtD
Metformin—Oedema peripheral—Epirubicin—bone cancer	7.77e-05	0.00265	CcSEcCtD
Metformin—Connective tissue disorder—Epirubicin—bone cancer	7.75e-05	0.00264	CcSEcCtD
Metformin—Hepatobiliary disease—Doxorubicin—bone cancer	7.69e-05	0.00262	CcSEcCtD
Metformin—Angiopathy—Methotrexate—bone cancer	7.65e-05	0.00261	CcSEcCtD
Metformin—Immune system disorder—Methotrexate—bone cancer	7.61e-05	0.00259	CcSEcCtD
Metformin—Mediastinal disorder—Methotrexate—bone cancer	7.6e-05	0.00259	CcSEcCtD
Metformin—Chills—Methotrexate—bone cancer	7.56e-05	0.00258	CcSEcCtD
Metformin—Diarrhoea—Cisplatin—bone cancer	7.47e-05	0.00254	CcSEcCtD
Metformin—Bradycardia—Doxorubicin—bone cancer	7.43e-05	0.00253	CcSEcCtD
Metformin—Eye disorder—Epirubicin—bone cancer	7.37e-05	0.00251	CcSEcCtD
Metformin—Malnutrition—Methotrexate—bone cancer	7.34e-05	0.0025	CcSEcCtD
Metformin—Erythema—Methotrexate—bone cancer	7.34e-05	0.0025	CcSEcCtD
Metformin—Cardiac disorder—Epirubicin—bone cancer	7.32e-05	0.00249	CcSEcCtD
Metformin—Flushing—Epirubicin—bone cancer	7.32e-05	0.00249	CcSEcCtD
Metformin—Rhinitis—Doxorubicin—bone cancer	7.32e-05	0.00249	CcSEcCtD
Metformin—Hepatitis—Doxorubicin—bone cancer	7.3e-05	0.00249	CcSEcCtD
Metformin—Hypoaesthesia—Doxorubicin—bone cancer	7.26e-05	0.00247	CcSEcCtD
Metformin—Oedema peripheral—Doxorubicin—bone cancer	7.19e-05	0.00245	CcSEcCtD
Metformin—Dysgeusia—Methotrexate—bone cancer	7.18e-05	0.00245	CcSEcCtD
Metformin—Connective tissue disorder—Doxorubicin—bone cancer	7.17e-05	0.00244	CcSEcCtD
Metformin—Angiopathy—Epirubicin—bone cancer	7.16e-05	0.00244	CcSEcCtD
Metformin—Immune system disorder—Epirubicin—bone cancer	7.12e-05	0.00243	CcSEcCtD
Metformin—Mediastinal disorder—Epirubicin—bone cancer	7.11e-05	0.00242	CcSEcCtD
Metformin—Chills—Epirubicin—bone cancer	7.08e-05	0.00241	CcSEcCtD
Metformin—Vomiting—Cisplatin—bone cancer	6.94e-05	0.00236	CcSEcCtD
Metformin—Vision blurred—Methotrexate—bone cancer	6.91e-05	0.00236	CcSEcCtD
Metformin—Rash—Cisplatin—bone cancer	6.88e-05	0.00234	CcSEcCtD
Metformin—Dermatitis—Cisplatin—bone cancer	6.87e-05	0.00234	CcSEcCtD
Metformin—Malnutrition—Epirubicin—bone cancer	6.87e-05	0.00234	CcSEcCtD
Metformin—Erythema—Epirubicin—bone cancer	6.87e-05	0.00234	CcSEcCtD
Metformin—Eye disorder—Doxorubicin—bone cancer	6.82e-05	0.00232	CcSEcCtD
Metformin—Ill-defined disorder—Methotrexate—bone cancer	6.81e-05	0.00232	CcSEcCtD
Metformin—Cardiac disorder—Doxorubicin—bone cancer	6.77e-05	0.00231	CcSEcCtD
Metformin—Flushing—Doxorubicin—bone cancer	6.77e-05	0.00231	CcSEcCtD
Metformin—Flatulence—Epirubicin—bone cancer	6.77e-05	0.00231	CcSEcCtD
Metformin—Dysgeusia—Epirubicin—bone cancer	6.72e-05	0.00229	CcSEcCtD
Metformin—Angiopathy—Doxorubicin—bone cancer	6.62e-05	0.00226	CcSEcCtD
Metformin—Malaise—Methotrexate—bone cancer	6.62e-05	0.00225	CcSEcCtD
Metformin—Muscle spasms—Epirubicin—bone cancer	6.6e-05	0.00225	CcSEcCtD
Metformin—Immune system disorder—Doxorubicin—bone cancer	6.59e-05	0.00225	CcSEcCtD
Metformin—Mediastinal disorder—Doxorubicin—bone cancer	6.58e-05	0.00224	CcSEcCtD
Metformin—Chills—Doxorubicin—bone cancer	6.55e-05	0.00223	CcSEcCtD
Metformin—Nausea—Cisplatin—bone cancer	6.48e-05	0.00221	CcSEcCtD
Metformin—Vision blurred—Epirubicin—bone cancer	6.47e-05	0.00221	CcSEcCtD
Metformin—Ill-defined disorder—Epirubicin—bone cancer	6.37e-05	0.00217	CcSEcCtD
Metformin—Erythema—Doxorubicin—bone cancer	6.35e-05	0.00217	CcSEcCtD
Metformin—Malnutrition—Doxorubicin—bone cancer	6.35e-05	0.00217	CcSEcCtD
Metformin—Flatulence—Doxorubicin—bone cancer	6.26e-05	0.00213	CcSEcCtD
Metformin—Myalgia—Methotrexate—bone cancer	6.25e-05	0.00213	CcSEcCtD
Metformin—Chest pain—Methotrexate—bone cancer	6.25e-05	0.00213	CcSEcCtD
Metformin—Dysgeusia—Doxorubicin—bone cancer	6.22e-05	0.00212	CcSEcCtD
Metformin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—bone cancer	6.2e-05	0.00211	CcSEcCtD
Metformin—Malaise—Epirubicin—bone cancer	6.19e-05	0.00211	CcSEcCtD
Metformin—Discomfort—Methotrexate—bone cancer	6.17e-05	0.0021	CcSEcCtD
Metformin—Syncope—Epirubicin—bone cancer	6.16e-05	0.0021	CcSEcCtD
Metformin—Muscle spasms—Doxorubicin—bone cancer	6.11e-05	0.00208	CcSEcCtD
Metformin—Palpitations—Epirubicin—bone cancer	6.07e-05	0.00207	CcSEcCtD
Metformin—Loss of consciousness—Epirubicin—bone cancer	6.03e-05	0.00206	CcSEcCtD
Metformin—Vision blurred—Doxorubicin—bone cancer	5.99e-05	0.00204	CcSEcCtD
Metformin—Infection—Methotrexate—bone cancer	5.95e-05	0.00203	CcSEcCtD
Metformin—Hypertension—Epirubicin—bone cancer	5.93e-05	0.00202	CcSEcCtD
Metformin—Ill-defined disorder—Doxorubicin—bone cancer	5.89e-05	0.00201	CcSEcCtD
Metformin—Nervous system disorder—Methotrexate—bone cancer	5.87e-05	0.002	CcSEcCtD
Metformin—Thrombocytopenia—Methotrexate—bone cancer	5.86e-05	0.002	CcSEcCtD
Metformin—Myalgia—Epirubicin—bone cancer	5.85e-05	0.00199	CcSEcCtD
Metformin—Chest pain—Epirubicin—bone cancer	5.85e-05	0.00199	CcSEcCtD
Metformin—Skin disorder—Methotrexate—bone cancer	5.82e-05	0.00198	CcSEcCtD
Metformin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—bone cancer	5.81e-05	0.00198	CcSEcCtD
Metformin—Hyperhidrosis—Methotrexate—bone cancer	5.79e-05	0.00197	CcSEcCtD
Metformin—Discomfort—Epirubicin—bone cancer	5.78e-05	0.00197	CcSEcCtD
Metformin—Malaise—Doxorubicin—bone cancer	5.73e-05	0.00195	CcSEcCtD
Metformin—Anorexia—Methotrexate—bone cancer	5.71e-05	0.00195	CcSEcCtD
Metformin—Syncope—Doxorubicin—bone cancer	5.7e-05	0.00194	CcSEcCtD
Metformin—Palpitations—Doxorubicin—bone cancer	5.61e-05	0.00191	CcSEcCtD
Metformin—Oedema—Epirubicin—bone cancer	5.6e-05	0.00191	CcSEcCtD
Metformin—Hypotension—Methotrexate—bone cancer	5.6e-05	0.00191	CcSEcCtD
Metformin—Loss of consciousness—Doxorubicin—bone cancer	5.58e-05	0.0019	CcSEcCtD
Metformin—Infection—Epirubicin—bone cancer	5.57e-05	0.0019	CcSEcCtD
Metformin—Shock—Epirubicin—bone cancer	5.51e-05	0.00188	CcSEcCtD
Metformin—Nervous system disorder—Epirubicin—bone cancer	5.5e-05	0.00187	CcSEcCtD
Metformin—Thrombocytopenia—Epirubicin—bone cancer	5.49e-05	0.00187	CcSEcCtD
Metformin—Hypertension—Doxorubicin—bone cancer	5.48e-05	0.00187	CcSEcCtD
Metformin—Musculoskeletal discomfort—Methotrexate—bone cancer	5.46e-05	0.00186	CcSEcCtD
Metformin—Skin disorder—Epirubicin—bone cancer	5.44e-05	0.00186	CcSEcCtD
Metformin—Hyperhidrosis—Epirubicin—bone cancer	5.42e-05	0.00185	CcSEcCtD
Metformin—Myalgia—Doxorubicin—bone cancer	5.41e-05	0.00184	CcSEcCtD
Metformin—Chest pain—Doxorubicin—bone cancer	5.41e-05	0.00184	CcSEcCtD
Metformin—Paraesthesia—Methotrexate—bone cancer	5.38e-05	0.00183	CcSEcCtD
Metformin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—bone cancer	5.37e-05	0.00183	CcSEcCtD
Metformin—Discomfort—Doxorubicin—bone cancer	5.34e-05	0.00182	CcSEcCtD
Metformin—Anorexia—Epirubicin—bone cancer	5.34e-05	0.00182	CcSEcCtD
Metformin—Dyspnoea—Methotrexate—bone cancer	5.34e-05	0.00182	CcSEcCtD
Metformin—Somnolence—Methotrexate—bone cancer	5.32e-05	0.00181	CcSEcCtD
Metformin—Dyspepsia—Methotrexate—bone cancer	5.27e-05	0.0018	CcSEcCtD
Metformin—Hypotension—Epirubicin—bone cancer	5.24e-05	0.00178	CcSEcCtD
Metformin—Decreased appetite—Methotrexate—bone cancer	5.21e-05	0.00177	CcSEcCtD
Metformin—Oedema—Doxorubicin—bone cancer	5.18e-05	0.00177	CcSEcCtD
Metformin—Gastrointestinal disorder—Methotrexate—bone cancer	5.17e-05	0.00176	CcSEcCtD
Metformin—Fatigue—Methotrexate—bone cancer	5.16e-05	0.00176	CcSEcCtD
Metformin—Infection—Doxorubicin—bone cancer	5.15e-05	0.00176	CcSEcCtD
Metformin—Musculoskeletal discomfort—Epirubicin—bone cancer	5.11e-05	0.00174	CcSEcCtD
Metformin—Shock—Doxorubicin—bone cancer	5.1e-05	0.00174	CcSEcCtD
Metformin—Nervous system disorder—Doxorubicin—bone cancer	5.08e-05	0.00173	CcSEcCtD
Metformin—Thrombocytopenia—Doxorubicin—bone cancer	5.08e-05	0.00173	CcSEcCtD
Metformin—Skin disorder—Doxorubicin—bone cancer	5.04e-05	0.00172	CcSEcCtD
Metformin—Paraesthesia—Epirubicin—bone cancer	5.03e-05	0.00171	CcSEcCtD
Metformin—Hyperhidrosis—Doxorubicin—bone cancer	5.01e-05	0.00171	CcSEcCtD
Metformin—Dyspnoea—Epirubicin—bone cancer	5e-05	0.0017	CcSEcCtD
Metformin—Somnolence—Epirubicin—bone cancer	4.98e-05	0.0017	CcSEcCtD
Metformin—Anorexia—Doxorubicin—bone cancer	4.94e-05	0.00168	CcSEcCtD
Metformin—Feeling abnormal—Methotrexate—bone cancer	4.93e-05	0.00168	CcSEcCtD
Metformin—Dyspepsia—Epirubicin—bone cancer	4.93e-05	0.00168	CcSEcCtD
Metformin—Gastrointestinal pain—Methotrexate—bone cancer	4.9e-05	0.00167	CcSEcCtD
Metformin—Decreased appetite—Epirubicin—bone cancer	4.87e-05	0.00166	CcSEcCtD
Metformin—Hypotension—Doxorubicin—bone cancer	4.84e-05	0.00165	CcSEcCtD
Metformin—Gastrointestinal disorder—Epirubicin—bone cancer	4.84e-05	0.00165	CcSEcCtD
Metformin—Fatigue—Epirubicin—bone cancer	4.83e-05	0.00165	CcSEcCtD
Metformin—Constipation—Epirubicin—bone cancer	4.79e-05	0.00163	CcSEcCtD
Metformin—Urticaria—Methotrexate—bone cancer	4.76e-05	0.00162	CcSEcCtD
Metformin—Abdominal pain—Methotrexate—bone cancer	4.73e-05	0.00161	CcSEcCtD
Metformin—Musculoskeletal discomfort—Doxorubicin—bone cancer	4.72e-05	0.00161	CcSEcCtD
Metformin—Paraesthesia—Doxorubicin—bone cancer	4.66e-05	0.00159	CcSEcCtD
Metformin—Dyspnoea—Doxorubicin—bone cancer	4.62e-05	0.00158	CcSEcCtD
Metformin—Feeling abnormal—Epirubicin—bone cancer	4.62e-05	0.00157	CcSEcCtD
Metformin—Somnolence—Doxorubicin—bone cancer	4.61e-05	0.00157	CcSEcCtD
Metformin—Gastrointestinal pain—Epirubicin—bone cancer	4.58e-05	0.00156	CcSEcCtD
Metformin—Dyspepsia—Doxorubicin—bone cancer	4.56e-05	0.00156	CcSEcCtD
Metformin—Decreased appetite—Doxorubicin—bone cancer	4.51e-05	0.00154	CcSEcCtD
Metformin—Gastrointestinal disorder—Doxorubicin—bone cancer	4.48e-05	0.00153	CcSEcCtD
Metformin—Fatigue—Doxorubicin—bone cancer	4.47e-05	0.00152	CcSEcCtD
Metformin—Urticaria—Epirubicin—bone cancer	4.45e-05	0.00152	CcSEcCtD
Metformin—Constipation—Doxorubicin—bone cancer	4.43e-05	0.00151	CcSEcCtD
Metformin—Abdominal pain—Epirubicin—bone cancer	4.43e-05	0.00151	CcSEcCtD
Metformin—Asthenia—Methotrexate—bone cancer	4.3e-05	0.00146	CcSEcCtD
Metformin—Feeling abnormal—Doxorubicin—bone cancer	4.27e-05	0.00146	CcSEcCtD
Metformin—Gastrointestinal pain—Doxorubicin—bone cancer	4.24e-05	0.00144	CcSEcCtD
Metformin—Pruritus—Methotrexate—bone cancer	4.24e-05	0.00144	CcSEcCtD
Metformin—Urticaria—Doxorubicin—bone cancer	4.12e-05	0.0014	CcSEcCtD
Metformin—Abdominal pain—Doxorubicin—bone cancer	4.1e-05	0.0014	CcSEcCtD
Metformin—Diarrhoea—Methotrexate—bone cancer	4.1e-05	0.0014	CcSEcCtD
Metformin—Asthenia—Epirubicin—bone cancer	4.02e-05	0.00137	CcSEcCtD
Metformin—Pruritus—Epirubicin—bone cancer	3.96e-05	0.00135	CcSEcCtD
Metformin—Dizziness—Methotrexate—bone cancer	3.96e-05	0.00135	CcSEcCtD
Metformin—Diarrhoea—Epirubicin—bone cancer	3.83e-05	0.00131	CcSEcCtD
Metformin—Vomiting—Methotrexate—bone cancer	3.81e-05	0.0013	CcSEcCtD
Metformin—Rash—Methotrexate—bone cancer	3.78e-05	0.00129	CcSEcCtD
Metformin—Dermatitis—Methotrexate—bone cancer	3.77e-05	0.00129	CcSEcCtD
Metformin—Headache—Methotrexate—bone cancer	3.75e-05	0.00128	CcSEcCtD
Metformin—Asthenia—Doxorubicin—bone cancer	3.72e-05	0.00127	CcSEcCtD
Metformin—Dizziness—Epirubicin—bone cancer	3.71e-05	0.00126	CcSEcCtD
Metformin—Pruritus—Doxorubicin—bone cancer	3.67e-05	0.00125	CcSEcCtD
Metformin—Vomiting—Epirubicin—bone cancer	3.56e-05	0.00121	CcSEcCtD
Metformin—Nausea—Methotrexate—bone cancer	3.56e-05	0.00121	CcSEcCtD
Metformin—Diarrhoea—Doxorubicin—bone cancer	3.55e-05	0.00121	CcSEcCtD
Metformin—Rash—Epirubicin—bone cancer	3.53e-05	0.0012	CcSEcCtD
Metformin—Dermatitis—Epirubicin—bone cancer	3.53e-05	0.0012	CcSEcCtD
Metformin—Headache—Epirubicin—bone cancer	3.51e-05	0.0012	CcSEcCtD
Metformin—Dizziness—Doxorubicin—bone cancer	3.43e-05	0.00117	CcSEcCtD
Metformin—Nausea—Epirubicin—bone cancer	3.33e-05	0.00113	CcSEcCtD
Metformin—Vomiting—Doxorubicin—bone cancer	3.3e-05	0.00112	CcSEcCtD
Metformin—Rash—Doxorubicin—bone cancer	3.27e-05	0.00111	CcSEcCtD
Metformin—Dermatitis—Doxorubicin—bone cancer	3.27e-05	0.00111	CcSEcCtD
Metformin—Headache—Doxorubicin—bone cancer	3.25e-05	0.00111	CcSEcCtD
Metformin—Nausea—Doxorubicin—bone cancer	3.08e-05	0.00105	CcSEcCtD
Metformin—NDUFA4—Metabolism—DHFR—bone cancer	2.34e-05	0.000204	CbGpPWpGaD
Metformin—NDUFV1—Metabolism—DHFR—bone cancer	2.34e-05	0.000204	CbGpPWpGaD
Metformin—NDUFAB1—Metabolism—DHFR—bone cancer	2.34e-05	0.000204	CbGpPWpGaD
Metformin—ND3—Metabolism—DHFR—bone cancer	2.34e-05	0.000204	CbGpPWpGaD
Metformin—NDUFB4—Metabolism—DHFR—bone cancer	2.34e-05	0.000204	CbGpPWpGaD
Metformin—NDUFS1—Metabolism—DHFR—bone cancer	2.34e-05	0.000204	CbGpPWpGaD
Metformin—NDUFS4—Metabolism—DHFR—bone cancer	2.34e-05	0.000204	CbGpPWpGaD
Metformin—NDUFB11—Metabolism—CYP3A4—bone cancer	2.33e-05	0.000204	CbGpPWpGaD
Metformin—NDUFV3—Metabolism—ENO2—bone cancer	2.24e-05	0.000196	CbGpPWpGaD
Metformin—ND4—Metabolism—GNA11—bone cancer	2.18e-05	0.000191	CbGpPWpGaD
Metformin—ND2—Metabolism—GNA11—bone cancer	2.18e-05	0.000191	CbGpPWpGaD
Metformin—NDUFS4—Metabolism—GNA11—bone cancer	2.18e-05	0.000191	CbGpPWpGaD
Metformin—NDUFS6—Metabolism—GNA11—bone cancer	2.18e-05	0.000191	CbGpPWpGaD
Metformin—NDUFB9—Metabolism—GNA11—bone cancer	2.18e-05	0.000191	CbGpPWpGaD
Metformin—NDUFB5—Metabolism—GNA11—bone cancer	2.18e-05	0.000191	CbGpPWpGaD
Metformin—ND4L—Metabolism—GNA11—bone cancer	2.18e-05	0.000191	CbGpPWpGaD
Metformin—NDUFA5—Metabolism—GNA11—bone cancer	2.18e-05	0.000191	CbGpPWpGaD
Metformin—NDUFS8—Metabolism—GNA11—bone cancer	2.18e-05	0.000191	CbGpPWpGaD
Metformin—ND6—Metabolism—GNA11—bone cancer	2.18e-05	0.000191	CbGpPWpGaD
Metformin—NDUFV2—Metabolism—GNA11—bone cancer	2.18e-05	0.000191	CbGpPWpGaD
Metformin—NDUFA4—Metabolism—GNA11—bone cancer	2.18e-05	0.000191	CbGpPWpGaD
Metformin—NDUFA13—Metabolism—GNA11—bone cancer	2.18e-05	0.000191	CbGpPWpGaD
Metformin—NDUFC1—Metabolism—GNA11—bone cancer	2.18e-05	0.000191	CbGpPWpGaD
Metformin—NDUFA3—Metabolism—GNA11—bone cancer	2.18e-05	0.000191	CbGpPWpGaD
Metformin—NDUFA8—Metabolism—GNA11—bone cancer	2.18e-05	0.000191	CbGpPWpGaD
Metformin—NDUFB8—Metabolism—GNA11—bone cancer	2.18e-05	0.000191	CbGpPWpGaD
Metformin—ND5—Metabolism—GNA11—bone cancer	2.18e-05	0.000191	CbGpPWpGaD
Metformin—NDUFS1—Metabolism—GNA11—bone cancer	2.18e-05	0.000191	CbGpPWpGaD
Metformin—NDUFA10—Metabolism—GNA11—bone cancer	2.18e-05	0.000191	CbGpPWpGaD
Metformin—NDUFB6—Metabolism—GNA11—bone cancer	2.18e-05	0.000191	CbGpPWpGaD
Metformin—NDUFS5—Metabolism—GNA11—bone cancer	2.18e-05	0.000191	CbGpPWpGaD
Metformin—NDUFA6—Metabolism—GNA11—bone cancer	2.18e-05	0.000191	CbGpPWpGaD
Metformin—NDUFB2—Metabolism—GNA11—bone cancer	2.18e-05	0.000191	CbGpPWpGaD
Metformin—ND3—Metabolism—GNA11—bone cancer	2.18e-05	0.000191	CbGpPWpGaD
Metformin—NDUFA2—Metabolism—GNA11—bone cancer	2.18e-05	0.000191	CbGpPWpGaD
Metformin—NDUFAB1—Metabolism—GNA11—bone cancer	2.18e-05	0.000191	CbGpPWpGaD
Metformin—NDUFV1—Metabolism—GNA11—bone cancer	2.18e-05	0.000191	CbGpPWpGaD
Metformin—NDUFA7—Metabolism—GNA11—bone cancer	2.18e-05	0.000191	CbGpPWpGaD
Metformin—NDUFB7—Metabolism—GNA11—bone cancer	2.18e-05	0.000191	CbGpPWpGaD
Metformin—NDUFB1—Metabolism—GNA11—bone cancer	2.18e-05	0.000191	CbGpPWpGaD
Metformin—NDUFA9—Metabolism—GNA11—bone cancer	2.18e-05	0.000191	CbGpPWpGaD
Metformin—NDUFB4—Metabolism—GNA11—bone cancer	2.18e-05	0.000191	CbGpPWpGaD
Metformin—NDUFB10—Metabolism—GNA11—bone cancer	2.18e-05	0.000191	CbGpPWpGaD
Metformin—NDUFA12—Metabolism—CYP3A4—bone cancer	2.13e-05	0.000186	CbGpPWpGaD
Metformin—NDUFA11—Metabolism—CYP3A4—bone cancer	2.13e-05	0.000186	CbGpPWpGaD
Metformin—NDUFB3—Metabolism—CYP3A4—bone cancer	2.13e-05	0.000186	CbGpPWpGaD
Metformin—NDUFA1—Metabolism—CYP3A4—bone cancer	2.13e-05	0.000186	CbGpPWpGaD
Metformin—NDUFV3—Metabolism—DHFR—bone cancer	2.08e-05	0.000182	CbGpPWpGaD
Metformin—SLC22A3—Transmembrane transport of small molecules—TUBB4B—bone cancer	2.02e-05	0.000177	CbGpPWpGaD
Metformin—NDUFB11—Metabolism—GSTP1—bone cancer	1.99e-05	0.000174	CbGpPWpGaD
Metformin—NDUFS5—Metabolism—CYP3A4—bone cancer	1.98e-05	0.000173	CbGpPWpGaD
Metformin—NDUFA8—Metabolism—CYP3A4—bone cancer	1.98e-05	0.000173	CbGpPWpGaD
Metformin—NDUFA5—Metabolism—CYP3A4—bone cancer	1.98e-05	0.000173	CbGpPWpGaD
Metformin—NDUFB1—Metabolism—CYP3A4—bone cancer	1.98e-05	0.000173	CbGpPWpGaD
Metformin—NDUFA4—Metabolism—CYP3A4—bone cancer	1.98e-05	0.000173	CbGpPWpGaD
Metformin—NDUFA13—Metabolism—CYP3A4—bone cancer	1.98e-05	0.000173	CbGpPWpGaD
Metformin—NDUFB7—Metabolism—CYP3A4—bone cancer	1.98e-05	0.000173	CbGpPWpGaD
Metformin—ND5—Metabolism—CYP3A4—bone cancer	1.98e-05	0.000173	CbGpPWpGaD
Metformin—NDUFA9—Metabolism—CYP3A4—bone cancer	1.98e-05	0.000173	CbGpPWpGaD
Metformin—NDUFS8—Metabolism—CYP3A4—bone cancer	1.98e-05	0.000173	CbGpPWpGaD
Metformin—ND3—Metabolism—CYP3A4—bone cancer	1.98e-05	0.000173	CbGpPWpGaD
Metformin—ND4—Metabolism—CYP3A4—bone cancer	1.98e-05	0.000173	CbGpPWpGaD
Metformin—ND6—Metabolism—CYP3A4—bone cancer	1.98e-05	0.000173	CbGpPWpGaD
Metformin—NDUFB10—Metabolism—CYP3A4—bone cancer	1.98e-05	0.000173	CbGpPWpGaD
Metformin—NDUFC1—Metabolism—CYP3A4—bone cancer	1.98e-05	0.000173	CbGpPWpGaD
Metformin—ND2—Metabolism—CYP3A4—bone cancer	1.98e-05	0.000173	CbGpPWpGaD
Metformin—NDUFA7—Metabolism—CYP3A4—bone cancer	1.98e-05	0.000173	CbGpPWpGaD
Metformin—ND4L—Metabolism—CYP3A4—bone cancer	1.98e-05	0.000173	CbGpPWpGaD
Metformin—NDUFB8—Metabolism—CYP3A4—bone cancer	1.98e-05	0.000173	CbGpPWpGaD
Metformin—NDUFS1—Metabolism—CYP3A4—bone cancer	1.98e-05	0.000173	CbGpPWpGaD
Metformin—NDUFB5—Metabolism—CYP3A4—bone cancer	1.98e-05	0.000173	CbGpPWpGaD
Metformin—NDUFB6—Metabolism—CYP3A4—bone cancer	1.98e-05	0.000173	CbGpPWpGaD
Metformin—NDUFA3—Metabolism—CYP3A4—bone cancer	1.98e-05	0.000173	CbGpPWpGaD
Metformin—NDUFAB1—Metabolism—CYP3A4—bone cancer	1.98e-05	0.000173	CbGpPWpGaD
Metformin—NDUFV1—Metabolism—CYP3A4—bone cancer	1.98e-05	0.000173	CbGpPWpGaD
Metformin—NDUFS6—Metabolism—CYP3A4—bone cancer	1.98e-05	0.000173	CbGpPWpGaD
Metformin—NDUFB4—Metabolism—CYP3A4—bone cancer	1.98e-05	0.000173	CbGpPWpGaD
Metformin—NDUFB9—Metabolism—CYP3A4—bone cancer	1.98e-05	0.000173	CbGpPWpGaD
Metformin—NDUFV2—Metabolism—CYP3A4—bone cancer	1.98e-05	0.000173	CbGpPWpGaD
Metformin—NDUFA10—Metabolism—CYP3A4—bone cancer	1.98e-05	0.000173	CbGpPWpGaD
Metformin—NDUFA6—Metabolism—CYP3A4—bone cancer	1.98e-05	0.000173	CbGpPWpGaD
Metformin—NDUFS4—Metabolism—CYP3A4—bone cancer	1.98e-05	0.000173	CbGpPWpGaD
Metformin—NDUFB2—Metabolism—CYP3A4—bone cancer	1.98e-05	0.000173	CbGpPWpGaD
Metformin—NDUFA2—Metabolism—CYP3A4—bone cancer	1.98e-05	0.000173	CbGpPWpGaD
Metformin—NDUFV3—Metabolism—GNA11—bone cancer	1.95e-05	0.00017	CbGpPWpGaD
Metformin—PRKAB1—Direct p53 effectors—EGFR—bone cancer	1.93e-05	0.000169	CbGpPWpGaD
Metformin—NDUFS3—Metabolism—ENO2—bone cancer	1.91e-05	0.000167	CbGpPWpGaD
Metformin—NDUFS7—Metabolism—ENO2—bone cancer	1.91e-05	0.000167	CbGpPWpGaD
Metformin—NDUFC2—Metabolism—ENO2—bone cancer	1.91e-05	0.000167	CbGpPWpGaD
Metformin—NDUFB3—Metabolism—GSTP1—bone cancer	1.82e-05	0.000159	CbGpPWpGaD
Metformin—NDUFA12—Metabolism—GSTP1—bone cancer	1.82e-05	0.000159	CbGpPWpGaD
Metformin—NDUFA1—Metabolism—GSTP1—bone cancer	1.82e-05	0.000159	CbGpPWpGaD
Metformin—NDUFA11—Metabolism—GSTP1—bone cancer	1.82e-05	0.000159	CbGpPWpGaD
Metformin—NDUFS2—Metabolism—ENO2—bone cancer	1.79e-05	0.000157	CbGpPWpGaD
Metformin—NDUFS7—Metabolism—DHFR—bone cancer	1.77e-05	0.000155	CbGpPWpGaD
Metformin—NDUFS3—Metabolism—DHFR—bone cancer	1.77e-05	0.000155	CbGpPWpGaD
Metformin—NDUFC2—Metabolism—DHFR—bone cancer	1.77e-05	0.000155	CbGpPWpGaD
Metformin—NDUFV3—Metabolism—CYP3A4—bone cancer	1.76e-05	0.000154	CbGpPWpGaD
Metformin—SLC22A3—Transmembrane transport of small molecules—TUBB2A—bone cancer	1.74e-05	0.000153	CbGpPWpGaD
Metformin—NDUFAB1—Metabolism—GSTP1—bone cancer	1.69e-05	0.000148	CbGpPWpGaD
Metformin—NDUFS5—Metabolism—GSTP1—bone cancer	1.69e-05	0.000148	CbGpPWpGaD
Metformin—NDUFA2—Metabolism—GSTP1—bone cancer	1.69e-05	0.000148	CbGpPWpGaD
Metformin—ND5—Metabolism—GSTP1—bone cancer	1.69e-05	0.000148	CbGpPWpGaD
Metformin—NDUFV2—Metabolism—GSTP1—bone cancer	1.69e-05	0.000148	CbGpPWpGaD
Metformin—ND4L—Metabolism—GSTP1—bone cancer	1.69e-05	0.000148	CbGpPWpGaD
Metformin—NDUFA3—Metabolism—GSTP1—bone cancer	1.69e-05	0.000148	CbGpPWpGaD
Metformin—NDUFA7—Metabolism—GSTP1—bone cancer	1.69e-05	0.000148	CbGpPWpGaD
Metformin—NDUFB5—Metabolism—GSTP1—bone cancer	1.69e-05	0.000148	CbGpPWpGaD
Metformin—NDUFA6—Metabolism—GSTP1—bone cancer	1.69e-05	0.000148	CbGpPWpGaD
Metformin—NDUFA4—Metabolism—GSTP1—bone cancer	1.69e-05	0.000148	CbGpPWpGaD
Metformin—ND3—Metabolism—GSTP1—bone cancer	1.69e-05	0.000148	CbGpPWpGaD
Metformin—NDUFB1—Metabolism—GSTP1—bone cancer	1.69e-05	0.000148	CbGpPWpGaD
Metformin—ND2—Metabolism—GSTP1—bone cancer	1.69e-05	0.000148	CbGpPWpGaD
Metformin—NDUFS1—Metabolism—GSTP1—bone cancer	1.69e-05	0.000148	CbGpPWpGaD
Metformin—NDUFC1—Metabolism—GSTP1—bone cancer	1.69e-05	0.000148	CbGpPWpGaD
Metformin—NDUFS6—Metabolism—GSTP1—bone cancer	1.69e-05	0.000148	CbGpPWpGaD
Metformin—NDUFB9—Metabolism—GSTP1—bone cancer	1.69e-05	0.000148	CbGpPWpGaD
Metformin—NDUFA8—Metabolism—GSTP1—bone cancer	1.69e-05	0.000148	CbGpPWpGaD
Metformin—NDUFA9—Metabolism—GSTP1—bone cancer	1.69e-05	0.000148	CbGpPWpGaD
Metformin—ND4—Metabolism—GSTP1—bone cancer	1.69e-05	0.000148	CbGpPWpGaD
Metformin—NDUFA5—Metabolism—GSTP1—bone cancer	1.69e-05	0.000148	CbGpPWpGaD
Metformin—NDUFB10—Metabolism—GSTP1—bone cancer	1.69e-05	0.000148	CbGpPWpGaD
Metformin—ND6—Metabolism—GSTP1—bone cancer	1.69e-05	0.000148	CbGpPWpGaD
Metformin—NDUFB8—Metabolism—GSTP1—bone cancer	1.69e-05	0.000148	CbGpPWpGaD
Metformin—NDUFS8—Metabolism—GSTP1—bone cancer	1.69e-05	0.000148	CbGpPWpGaD
Metformin—NDUFA13—Metabolism—GSTP1—bone cancer	1.69e-05	0.000148	CbGpPWpGaD
Metformin—NDUFB2—Metabolism—GSTP1—bone cancer	1.69e-05	0.000148	CbGpPWpGaD
Metformin—NDUFB6—Metabolism—GSTP1—bone cancer	1.69e-05	0.000148	CbGpPWpGaD
Metformin—NDUFV1—Metabolism—GSTP1—bone cancer	1.69e-05	0.000148	CbGpPWpGaD
Metformin—NDUFA10—Metabolism—GSTP1—bone cancer	1.69e-05	0.000148	CbGpPWpGaD
Metformin—NDUFS4—Metabolism—GSTP1—bone cancer	1.69e-05	0.000148	CbGpPWpGaD
Metformin—NDUFB4—Metabolism—GSTP1—bone cancer	1.69e-05	0.000148	CbGpPWpGaD
Metformin—NDUFB7—Metabolism—GSTP1—bone cancer	1.69e-05	0.000148	CbGpPWpGaD
Metformin—NDUFS2—Metabolism—DHFR—bone cancer	1.66e-05	0.000146	CbGpPWpGaD
Metformin—NDUFS7—Metabolism—GNA11—bone cancer	1.65e-05	0.000145	CbGpPWpGaD
Metformin—NDUFS3—Metabolism—GNA11—bone cancer	1.65e-05	0.000145	CbGpPWpGaD
Metformin—NDUFC2—Metabolism—GNA11—bone cancer	1.65e-05	0.000145	CbGpPWpGaD
Metformin—PRKAB1—Direct p53 effectors—TP53—bone cancer	1.62e-05	0.000142	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—NDUFA12—bone cancer	1.58e-05	0.000138	CbGpPWpGaD
Metformin—NDUFS2—Metabolism—GNA11—bone cancer	1.56e-05	0.000136	CbGpPWpGaD
Metformin—NDUFV3—Metabolism—GSTP1—bone cancer	1.51e-05	0.000132	CbGpPWpGaD
Metformin—NDUFC2—Metabolism—CYP3A4—bone cancer	1.5e-05	0.000131	CbGpPWpGaD
Metformin—NDUFS7—Metabolism—CYP3A4—bone cancer	1.5e-05	0.000131	CbGpPWpGaD
Metformin—NDUFS3—Metabolism—CYP3A4—bone cancer	1.5e-05	0.000131	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—GRM4—bone cancer	1.47e-05	0.000129	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—RGS1—bone cancer	1.47e-05	0.000129	CbGpPWpGaD
Metformin—NDUFS2—Metabolism—CYP3A4—bone cancer	1.41e-05	0.000123	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—NT5C3A—bone cancer	1.31e-05	0.000114	CbGpPWpGaD
Metformin—NDUFC2—Metabolism—GSTP1—bone cancer	1.28e-05	0.000112	CbGpPWpGaD
Metformin—NDUFS7—Metabolism—GSTP1—bone cancer	1.28e-05	0.000112	CbGpPWpGaD
Metformin—NDUFS3—Metabolism—GSTP1—bone cancer	1.28e-05	0.000112	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—GRM1—bone cancer	1.28e-05	0.000112	CbGpPWpGaD
Metformin—SLC22A2—Transmembrane transport of small molecules—TUBB4B—bone cancer	1.27e-05	0.000111	CbGpPWpGaD
Metformin—ND1—Metabolism—ENO2—bone cancer	1.23e-05	0.000108	CbGpPWpGaD
Metformin—NDUFS2—Metabolism—GSTP1—bone cancer	1.21e-05	0.000106	CbGpPWpGaD
Metformin—SLC22A1—Transmembrane transport of small molecules—TUBB4B—bone cancer	1.18e-05	0.000103	CbGpPWpGaD
Metformin—ND1—Metabolism—DHFR—bone cancer	1.14e-05	9.98e-05	CbGpPWpGaD
Metformin—SLC22A2—Transmembrane transport of small molecules—TUBB2A—bone cancer	1.09e-05	9.57e-05	CbGpPWpGaD
Metformin—ND1—Metabolism—GNA11—bone cancer	1.07e-05	9.33e-05	CbGpPWpGaD
Metformin—NDUFB11—Metabolism—PTGS2—bone cancer	1.03e-05	9.03e-05	CbGpPWpGaD
Metformin—SLC22A1—Transmembrane transport of small molecules—TUBB2A—bone cancer	1.02e-05	8.92e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—NDUFA12—bone cancer	9.9e-06	8.66e-05	CbGpPWpGaD
Metformin—ND1—Metabolism—CYP3A4—bone cancer	9.66e-06	8.46e-05	CbGpPWpGaD
Metformin—NDUFA11—Metabolism—PTGS2—bone cancer	9.43e-06	8.26e-05	CbGpPWpGaD
Metformin—NDUFA12—Metabolism—PTGS2—bone cancer	9.43e-06	8.26e-05	CbGpPWpGaD
Metformin—NDUFA1—Metabolism—PTGS2—bone cancer	9.43e-06	8.26e-05	CbGpPWpGaD
Metformin—NDUFB3—Metabolism—PTGS2—bone cancer	9.43e-06	8.26e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—NDUFA12—bone cancer	9.23e-06	8.08e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—SMO—bone cancer	8.99e-06	7.87e-05	CbGpPWpGaD
Metformin—ND4L—Metabolism—PTGS2—bone cancer	8.77e-06	7.68e-05	CbGpPWpGaD
Metformin—NDUFA4—Metabolism—PTGS2—bone cancer	8.77e-06	7.68e-05	CbGpPWpGaD
Metformin—NDUFC1—Metabolism—PTGS2—bone cancer	8.77e-06	7.68e-05	CbGpPWpGaD
Metformin—NDUFA6—Metabolism—PTGS2—bone cancer	8.77e-06	7.68e-05	CbGpPWpGaD
Metformin—NDUFB1—Metabolism—PTGS2—bone cancer	8.77e-06	7.68e-05	CbGpPWpGaD
Metformin—ND5—Metabolism—PTGS2—bone cancer	8.77e-06	7.68e-05	CbGpPWpGaD
Metformin—NDUFB5—Metabolism—PTGS2—bone cancer	8.77e-06	7.68e-05	CbGpPWpGaD
Metformin—NDUFS5—Metabolism—PTGS2—bone cancer	8.77e-06	7.68e-05	CbGpPWpGaD
Metformin—NDUFS1—Metabolism—PTGS2—bone cancer	8.77e-06	7.68e-05	CbGpPWpGaD
Metformin—NDUFV1—Metabolism—PTGS2—bone cancer	8.77e-06	7.68e-05	CbGpPWpGaD
Metformin—NDUFA13—Metabolism—PTGS2—bone cancer	8.77e-06	7.68e-05	CbGpPWpGaD
Metformin—NDUFA5—Metabolism—PTGS2—bone cancer	8.77e-06	7.68e-05	CbGpPWpGaD
Metformin—NDUFB9—Metabolism—PTGS2—bone cancer	8.77e-06	7.68e-05	CbGpPWpGaD
Metformin—ND6—Metabolism—PTGS2—bone cancer	8.77e-06	7.68e-05	CbGpPWpGaD
Metformin—NDUFA7—Metabolism—PTGS2—bone cancer	8.77e-06	7.68e-05	CbGpPWpGaD
Metformin—NDUFA3—Metabolism—PTGS2—bone cancer	8.77e-06	7.68e-05	CbGpPWpGaD
Metformin—ND3—Metabolism—PTGS2—bone cancer	8.77e-06	7.68e-05	CbGpPWpGaD
Metformin—NDUFB7—Metabolism—PTGS2—bone cancer	8.77e-06	7.68e-05	CbGpPWpGaD
Metformin—NDUFS4—Metabolism—PTGS2—bone cancer	8.77e-06	7.68e-05	CbGpPWpGaD
Metformin—ND2—Metabolism—PTGS2—bone cancer	8.77e-06	7.68e-05	CbGpPWpGaD
Metformin—NDUFA10—Metabolism—PTGS2—bone cancer	8.77e-06	7.68e-05	CbGpPWpGaD
Metformin—NDUFAB1—Metabolism—PTGS2—bone cancer	8.77e-06	7.68e-05	CbGpPWpGaD
Metformin—NDUFB6—Metabolism—PTGS2—bone cancer	8.77e-06	7.68e-05	CbGpPWpGaD
Metformin—NDUFV2—Metabolism—PTGS2—bone cancer	8.77e-06	7.68e-05	CbGpPWpGaD
Metformin—NDUFS8—Metabolism—PTGS2—bone cancer	8.77e-06	7.68e-05	CbGpPWpGaD
Metformin—NDUFA2—Metabolism—PTGS2—bone cancer	8.77e-06	7.68e-05	CbGpPWpGaD
Metformin—NDUFA8—Metabolism—PTGS2—bone cancer	8.77e-06	7.68e-05	CbGpPWpGaD
Metformin—NDUFB8—Metabolism—PTGS2—bone cancer	8.77e-06	7.68e-05	CbGpPWpGaD
Metformin—NDUFS6—Metabolism—PTGS2—bone cancer	8.77e-06	7.68e-05	CbGpPWpGaD
Metformin—NDUFB4—Metabolism—PTGS2—bone cancer	8.77e-06	7.68e-05	CbGpPWpGaD
Metformin—ND4—Metabolism—PTGS2—bone cancer	8.77e-06	7.68e-05	CbGpPWpGaD
Metformin—NDUFB10—Metabolism—PTGS2—bone cancer	8.77e-06	7.68e-05	CbGpPWpGaD
Metformin—NDUFB2—Metabolism—PTGS2—bone cancer	8.77e-06	7.68e-05	CbGpPWpGaD
Metformin—NDUFA9—Metabolism—PTGS2—bone cancer	8.77e-06	7.68e-05	CbGpPWpGaD
Metformin—ND1—Metabolism—GSTP1—bone cancer	8.27e-06	7.24e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—GNA11—bone cancer	8.23e-06	7.2e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—NT5C3A—bone cancer	8.2e-06	7.18e-05	CbGpPWpGaD
Metformin—SLC22A2—Transmission across Chemical Synapses—BRAF—bone cancer	8.03e-06	7.03e-05	CbGpPWpGaD
Metformin—NDUFV3—Metabolism—PTGS2—bone cancer	7.81e-06	6.84e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—ATF1—bone cancer	7.65e-06	6.69e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—NT5C3A—bone cancer	7.64e-06	6.69e-05	CbGpPWpGaD
Metformin—SLC22A1—Transmission across Chemical Synapses—BRAF—bone cancer	7.48e-06	6.55e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—IL3—bone cancer	7.46e-06	6.53e-05	CbGpPWpGaD
Metformin—SLC22A2—Transmission across Chemical Synapses—MDM2—bone cancer	6.73e-06	5.89e-05	CbGpPWpGaD
Metformin—NDUFS3—Metabolism—PTGS2—bone cancer	6.64e-06	5.82e-05	CbGpPWpGaD
Metformin—NDUFS7—Metabolism—PTGS2—bone cancer	6.64e-06	5.82e-05	CbGpPWpGaD
Metformin—NDUFC2—Metabolism—PTGS2—bone cancer	6.64e-06	5.82e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—TGFBR2—bone cancer	6.38e-06	5.58e-05	CbGpPWpGaD
Metformin—SLC22A1—Transmission across Chemical Synapses—MDM2—bone cancer	6.27e-06	5.49e-05	CbGpPWpGaD
Metformin—NDUFS2—Metabolism—PTGS2—bone cancer	6.25e-06	5.47e-05	CbGpPWpGaD
Metformin—SLC22A2—Neuronal System—BRAF—bone cancer	6.15e-06	5.39e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—IGF1R—bone cancer	6e-06	5.25e-05	CbGpPWpGaD
Metformin—SLC22A1—Neuronal System—BRAF—bone cancer	5.73e-06	5.02e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—ENO2—bone cancer	5.73e-06	5.01e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—DHFR—bone cancer	5.31e-06	4.65e-05	CbGpPWpGaD
Metformin—SLC22A2—Neuronal System—MDM2—bone cancer	5.15e-06	4.51e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—GNA11—bone cancer	4.97e-06	4.35e-05	CbGpPWpGaD
Metformin—SLC22A1—Neuronal System—MDM2—bone cancer	4.8e-06	4.21e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—CYP3A4—bone cancer	4.5e-06	3.94e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—KIT—bone cancer	4.35e-06	3.81e-05	CbGpPWpGaD
Metformin—ND1—Metabolism—PTGS2—bone cancer	4.28e-06	3.75e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—BRAF—bone cancer	4.09e-06	3.58e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—GSTP1—bone cancer	3.85e-06	3.37e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—ENO2—bone cancer	3.59e-06	3.14e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—MDM2—bone cancer	3.43e-06	3e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—ENO2—bone cancer	3.35e-06	2.93e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—DHFR—bone cancer	3.33e-06	2.92e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—GNA11—bone cancer	3.11e-06	2.73e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—DHFR—bone cancer	3.11e-06	2.72e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—JUN—bone cancer	2.98e-06	2.61e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—GNA11—bone cancer	2.9e-06	2.54e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—MMP9—bone cancer	2.9e-06	2.54e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—CYP3A4—bone cancer	2.82e-06	2.47e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—CYP3A4—bone cancer	2.63e-06	2.3e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—GSTP1—bone cancer	2.42e-06	2.11e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—EGFR—bone cancer	2.34e-06	2.05e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—GSTP1—bone cancer	2.25e-06	1.97e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—PTGS2—bone cancer	1.99e-06	1.75e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—TP53—bone cancer	1.97e-06	1.72e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—PTGS2—bone cancer	1.25e-06	1.1e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—PTGS2—bone cancer	1.17e-06	1.02e-05	CbGpPWpGaD
